Skip to main content
TipRanks
Go Ultimate75% OFF

Michael Gibertini Insider Profile

4 Followers

Michael Gibertini, President, Clinical Dev at Intercure, holds 47.28K shares in Syneos Health (Ticker: SYNH), holds 78.36K shares in Intercure (Ticker: IL:INCR).

Michael Gibertini's Trading History

SYNH
Syneos Health
Jul 03, 2017―Uninformative Sell33.70K$2.03M
INCR
Intercure
Jun 07, 2016President, Clinical DevUninformative Buy1.74M95.99M

You May Also Like

Michael Gibertini insider profile FAQ

What is the percentage of profitable transactions made by Michael Gibertini?
The percentage of profitable transactions made by Michael Gibertini is 0%.
What is the average return per transaction made by Michael Gibertini?
The average return per transaction made by Michael Gibertini is -41.20%.
What stocks does Michael Gibertini hold?
Michael Gibertini holds: IL:INCR, SYNH stocks.
What was Michael Gibertini’s latest transaction?
Michael Gibertini’s latest transaction was an Uninformative Sell of $33.70K.
What was Michael Gibertini's most profitable transaction?
Michael Gibertini’s most profitable transaction was an Informative Sell of IL:INCR stock on February 2, 2016. The return on the trade was -29.30%.
What is Michael Gibertini's role in Intercure?
Michael Gibertini's role in Intercure is President, Clinical Dev.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.